Abstracts Archive - Page 136 of 1683 - ATC Abstracts

2022 American Transplant Congress
Antibody-Mediated Kidney Allograft Rejection (ABMR) Monitoring and Intervention Based on ABMR Subtypes – A Step Towards Precision Diagnosis and Management
A. Rizvi¹, S. Hussain², M. Kueht³, J. Fair³, A. Gamilla-Crudo⁴, M. Mujtaba⁴
¹Internal Medicine, Nephrology, University of Texas Medical Branch, Galveston, TX, ²University of Texas Medical Branch, Houston, TX, ³Surgery, University of Texas Medical Branch, Galveston, TX, ⁴University of Texas Medical Branch, Galveston, TX
*Purpose: The monitoring of kidney allograft for early detection of antibody mediated rejection (ABMR) and subsequent intervention using traditional clinical parameters has been insufficient due…
2022 American Transplant Congress
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests
M. M. Nasrallah¹, M. Elalfy¹, Y. Elmesseery², I. Amer¹, P. Malvezzi³, L. Rostaing⁴
¹Misr International Hospital, Cairo, Egypt, ²Misr International Hospital, Caire, Egypt, ³CHU Grenoble-Alpes, Grenoble, France, ⁴Service de Néphrologie, CHU Grenoble-Alpes, Grenoble, France
*Purpose: Resistance to the action of rituximab (RTX), has been documented in several diseases. More recently, obinutuzumab (OBZ) has shown promise where RTX has failed…
2022 American Transplant Congress
Defatting of Steatotic Liver Grafts by Normothermic Ex Vivo Liver Machine Perfusion with 2,4 Dinitrophenol
J. M. Gassner¹, J. Michelotto¹, S. Moosburner¹, F. Strobl¹, A. L. Birkenfeld², A. Kurzbach², G. Shulman³, X. Zhang³, M. Selzner⁴, Y. Noguchi⁴, J. Pratschke¹, I. M. Sauer¹, N. Raschzok¹
¹Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, Berlin, Germany, ²Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal, University Hospital Tübingen, Tübingen, Germany, ³Departments of Internal Medicine and Cellular & Molecular Physiology, Yale Diabetes Research Center, Yale School of Medicine, New Haven, CT, ⁴Multi Organ Transplant Program, Ajmera Family Transplant Center, Toronto General Hospital, University of Toronto, Toronto, ON, Canada
*Purpose: The purpose of the study is to demonstrate that steatotic liver grafts can be defatted by normothermic ex vivo liver machine perfusion (NEVLP) with…
2022 American Transplant Congress
The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study
R. D. Foresto¹, H. Fagundes², V. Lafico², H. Tedesco Silva Junior², M. P. Cristelli¹, J. Pestana¹
¹Hospital do Rim, Sao Paulo, Brazil, ²Hospital do Rim, Universidade Federal de São Paulo, SAo Paulo, Brazil
*Purpose: This study aimed to assess changes in renal function during the acute disease and up to three months after the onset of symptoms among…
2022 American Transplant Congress
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Cytomegalovirus (CMV) is the most common viral infection that occurs after solid organ transplantation. The incidence of CMV infection or disease (I/d) varies based…
2022 American Transplant Congress
Risk of Clostridioides Difficile Infection After Kidney Transplant
C. Thomas¹, B. Crowther², K. Schwarz², D. Chen¹, Y. Shandaliy¹, K. Johnson¹, P. Klem²
¹Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, ²Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Hospital System, Aurora, CO
*Purpose: For patients undergoing kidney transplant, the risk of developing Clostridioides difficle infection (CDI) is reported to be 4.7%, likely due to risk factors such…
2022 American Transplant Congress
The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma
K. Sasaki¹, S. Kimura², K. Tomiyama³, Y. Bekki⁴, M. Murray³, P. Huang³, M. Fruscione², A. Moro⁵, C. Kwon⁶
¹Stanford University, Stanford, CA, ²Massachusetts General Hospital, Boston, MA, ³University of Rochester, Rochester, NY, ⁴Mount Sinai Medical Center, New York, NY, ⁵University of South Florida, Tampa, FL, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: Chronic hepatitis C infection (HCV) is one of the most common causes of hepatocellular carcinoma. After emerging direct-acting agents (DAA), the success rate of…
2022 American Transplant Congress
Assessment of Pain Management Regimens After Living Donor Nephrectomy
M. Lebin¹, B. Crowther², K. Klingenberg², V. Lewis², K. Moller², H. Moore², K. Way², C. Lyda², A. Howell², R. Cooke³, P. Klem²
¹University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, ²University of Colorado Hospital, Aurora, CO, ³Boulder Community Hospital, Boulder, CO
*Purpose: Opioid sparing pain control protocols are widely accepted within health systems nationwide. In living donor kidney transplantation, pain control is addressed in a multimodal…
2022 American Transplant Congress
Hepatitis C (HCV) Positive Recipients and/or Donors in Pancreas Transplantation – A Registry Analysis
A. C. Gruessner, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Pancreas transplantation (PT) is the best long-term option for patients with labile diabetes and end-stage-renal disease. The mortality on the waitlist is high; patients…
2022 American Transplant Congress
Phenytoin To Expedite Sirolimus & Tacrolimus Elimination: A Case Report
A. Lemke, B. A. Boilson, R. Razonable, S. A. Bernard
Mayo Clinic, Rochester, MN
*Purpose: Sirolimus (SIR), a mammalian target of rapamycin inhibitor (mTORi), may be used with or without a calcineurin inhibitor after heart transplant (HT). The anti-proliferative…